VPS33A Protein

VPS33A Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">VPS33A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Vacuolar Protein Sorting 33 Homolog A</td></tr>
<tr><td><strong>Gene</strong></td><td>[VPS33A](/genes/vps33a)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NXD1](https://www.uniprot.org/uniprotkb/Q9NXD1/entry)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>552 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>57.7 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Synaptic vesicles, lysosomes, endosomes</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Sec1/Munc18 (SM) family</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>5W5V, 6H4J</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
</div>

Overview

VPS33A Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">VPS33A Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Vacuolar Protein Sorting 33 Homolog A</td></tr>
<tr><td><strong>Gene</strong></td><td>[VPS33A](/genes/vps33a)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NXD1](https://www.uniprot.org/uniprotkb/Q9NXD1/entry)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>552 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>57.7 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Synaptic vesicles, lysosomes, endosomes</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Sec1/Munc18 (SM) family</td></tr>
<tr><td><strong>PDB Structures</strong></td><td>5W5V, 6H4J</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
</div>

Overview

VPS33A (Vacuolar Protein Sorting 33 Homolog A) is a member of the Sec1/Munc18 (SM) family of proteins that play critical roles in membrane fusion events throughout the cell[@uniprot_vps33a]. VPS33A is particularly important for synaptic vesicle trafficking, lysosomal function, and autophagy—processes that are central to neuronal health and frequently dysregulated in neurodegenerative diseases. Originally identified in yeast as a component of the vacuolar protein sorting (VPS) pathway, VPS33A has emerged as a significant protein in Parkinson's disease (PD), where genetic variants and functional deficits have been linked to disease pathogenesis[@iyer2019].

The SM protein family includes key regulators of vesicle trafficking, with VPS33A specifically functioning as a regulator of SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) complex assembly and disassembly. In neurons, VPS33A localizes to synaptic vesicles where it controls neurotransmitter release, and to lysosomes and endosomes where it regulates membrane trafficking pathways critical for cellular homeostasis[@hermey2018].

Structure

VPS33A protein contains several structural features that mediate its diverse cellular functions:

Sec1 Domain (Amino Acids 1-350)

The central Sec1 domain of VPS33A shares homology with other SM proteins:

• Forms a saddle-shaped structure that binds to SNARE proteins
• Contains a "winged-helix" domain for membrane interaction
• Multiple surfaces for protein-protein interactions

N-Terminal Region (Amino Acids 1-100)

The N-terminal region contains:

• Binding sites for syntaxin-1 and other t-SNAREs
• Phosphorylation sites that regulate protein activity
• Localization signals for synaptic vesicles

C-Terminal Region (Amino Acids 350-552)

The C-terminal region includes:

• Protein interaction domains for HOPS complex members
• Membrane-binding surfaces
• Lysosomal targeting signals

HOPS Complex Interface

VPS33A functions as part of the HOPS (Homotypic fusion and Vacuole Protein Sorting) complex:

• Forms heteromeric complexes with VPS16, VPS18, VPS33B, and VPS39
• HOPS specifically mediates lysosomal and vacuolar fusion events
• VPS33A serves as the SNARE-binding subunit

Normal Function

Synaptic Vesicle Trafficking

VPS33A plays a critical role in synaptic vesicle cycling:

SNARE Complex Regulation:

• Interacts with syntaxin-1 to regulate SNAP-25/SNARE complex formation[@dowlatshahi2015]
• Facilitates synaptic vesicle priming before fusion
• Controls the rate of synaptic vesicle replenishment

• Localizes to synaptic vesicle pools
• Regulates vesicle mobilization from reserve pools
• Ensures proper vesicle recycling after exocytosis

• Modulates the size of the readily releasable pool of synaptic vesicles
• Regulates release probability at central synapses[@bal2019]
• Controls synchronous and asynchronous release modes

Lysosomal Function

VPS33A is essential for lysosomal membrane trafficking:

Lysosomal Fusion:

• Part of the HOPS complex that mediates homotypic lysosomal fusion
• Regulates late endosome-lysosome fusion events
• Essential for lysosomal enzyme delivery and function

• Regulates autophagosome-lysosome fusion during autophagy[@wang2017]
• Critical for bulk degradation of cellular components
• Involved in selective autophagy pathways including mitophagy

Endosomal Trafficking

VPS33A functions in endosomal sorting:

Endocytic Pathway:

• Regulates cargo trafficking through early and late endosomes[@kelley2019]
• Controls receptor recycling and degradation
• Essential for proper endolysosomal system function

• Sorts transmembrane proteins for degradation or recycling
• Regulates the formation of multivesicular bodies
• Coordinates lysosomal targeting

Expression in the Brain

VPS33A shows specific expression patterns in the nervous system:

• High expression in the [basal ganglia](/brain-regions/basal-ganglia), particularly in the [striatum](/brain-regions/striatum)
• Present in dopaminergic neurons of the [substantia nigra](/brain-regions/substantia-nigra)
• Enriched in presynaptic terminals
• Expressed in both excitatory and inhibitory neurons

Role in Neurodegenerative Disease

Parkinson's Disease (PD)

VPS33A has emerged as a significant player in PD pathogenesis:

Genetic Evidence:

• VPS33A polymorphisms are associated with PD risk in genome-wide association studies (GWAS)[@iyer2019]
• Rare coding variants identified in early-onset PD patients[@chen2020]
• VPS33A lies in a genomic region linked to familial PD

• VPS33A deficiency leads to impaired autophagic clearance of alpha-synuclein[@safronova2019]
• Altered lysosomal function in VPS33A-deficient neurons
• Dysregulated neurotransmitter release in PD models

• Impaired autophagy leads to accumulation of toxic protein aggregates
• Lysosomal dysfunction disrupts cellular waste clearance
• Synaptic vesicle trafficking defects contribute to dopaminergic neuron vulnerability

• Altered VPS33A expression in PD brain tissue
• Colocalization with Lewy body pathology in some cases
• Interaction with other PD-linked proteins

Alzheimer's Disease (AD)

VPS33A involvement in AD includes:

Autophagy Dysregulation:

• Impaired autophagic flux in AD neurons
• VPS33A may contribute to defective autophagy-lysosome pathway
• Accumulation of autophagic vacuoles in AD brain

• Lysosomal deficits are a hallmark of AD
• VPS33A dysfunction may exacerbate lysosomal impairment
• Connection to APP processing and Aβ clearance

• VPS33A regulates synaptic vesicle cycling
• Synaptic vesicle defects in AD models
• Potential for VPS33A-based therapeutic approaches

Other Neurodegenerative Conditions

Huntington's Disease (HD):

• Mutant huntingtin disrupts autophagy
• VPS33A may be affected in HD models
• Potential for modulating autophagic flux

• VPS33A dysfunction can cause or modify lysosomal disease
• Connection to trafficking defects in various storage disorders
• Therapeutic target for lysosomal enhancement strategies

• Altered autophagy in motor neurons
• Potential VPS33A involvement in protein aggregate clearance
• Synaptic function defects

Therapeutic Implications

Targeting VPS33A Function

Small Molecule Approaches:

• Compounds that enhance VPS33A expression or activity
• Modulators of SNARE complex assembly
• Autophagy-enhancing compounds

• Viral vector delivery of VPS33A to specific brain regions
• CRISPR-based approaches for VPS33A correction
• Allele-specific targeting for PD-associated variants

Autophagy Enhancement

Autophagy Modulators:

• Enhancing autophagosome-lysosome fusion through VPS33A
• Targeting upstream autophagy pathways
• Combination approaches with other autophagy proteins

• Improving lysosomal function in neurodegenerative diseases
• Enhancing enzyme delivery to lysosomes
• Targeting lysosomal trafficking pathways

Combination Strategies

• VPS33A enhancement + autophagy inducers
• Synaptic protection + lysosomal enhancement
• Gene therapy + small molecule approaches

Interacting Proteins

| Interactor | Function | Reference |
|------------|----------|-----------|
| [VPS16](/genes/vps16) | HOPS complex subunit | [@sato2011] |
| VPS18 | HOPS complex subunit | [@sato2011] |
| VPS33B | HOPS complex subunit | [@sato2011] |
| VPS39 | HOPS complex subunit | [@sato2011] |
| Syntaxin-1 | SNARE protein | [@dowlatshahi2015] |
| SNAP-25 | SNARE protein | [@bal2019] |
| VAMP2 | Synaptic vesicle SNARE | [@yu2018] |
| LAMP1 | Lysosomal membrane protein | [@gupta2019] |

Research Methods

Protein Analysis:

• Co-immunoprecipitation for interaction studies
• Western blotting for expression analysis
• Mass spectrometry for complex composition

• CRISPR knockout in neurons
• Live-cell imaging of lysosomal trafficking
• Synaptic vesicle cycling assays

• Knockout mice with behavioral analysis
• Drosophila models for synaptic function
• Zebrafish models for development

• Genetic screening in PD cohorts
• Post-mortem brain analysis
• iPSC-derived neurons from PD patients

Summary

VPS33A is a critical regulator of synaptic vesicle trafficking, lysosomal function, and autophagy—processes essential for neuronal health and frequently dysregulated in neurodegenerative diseases. Its identification as a PD risk factor, combined with its fundamental roles in cellular trafficking pathways, makes VPS33A a protein of significant therapeutic interest. Understanding how VPS33A dysfunction contributes to neurodegeneration and developing approaches to restore its function may provide novel treatments for PD and related disorders.

See Also

• [VPS33A Gene](/genes/vps33a)
• [VPS33B Protein](/proteins/vps33b-protein)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Vesicle Cycling](/mechanisms/synaptic-vesicle-cycling)
• [Autophagy](/mechanisms/autophagy)
• [Lysosomal Function](/mechanisms/lysosomal-function)

External Links

• [UniProt: VPS33A](https://www.uniprot.org/uniprotkb/Q9NXD1/entry)
• [NCBI Protein: VPS33A](https://www.ncbi.nlm.nih.gov/protein)
• [PDB: VPS33A structures](https://www.rcsb.org/)
• [PD Gene: VPS33A](https://www.pdgene.org/)

References